Bova Score for Pulmonary Embolism Complications

The Bova Score identifies normotensive pulmonary embolism patients at increased risk for early complications such as hemodynamic deterioration or PE-related death.

Systolic BP
> 100 mmHg090-100 mmHg+2
Elevated cardiac troponin
No0Yes+2
RV dysfunction
No0Yes+2
HR/bpm
< 1000≥ 110+1

Indications for Use

Used in hemodynamically stable, normotensive acute PE to identify patients at intermediate‑risk of early complications (30‑day PE‑related death, hemodynamic collapse, or recurrent PE). Helps determine need for closer monitoring or consideration of escalated therapy. A 4‑variable model (SBP 90–100, HR ≥110, elevated troponin, RV dysfunction) predicts escalating risk stages with 4.2%, 10.8%, and 29.2% complication rates 1 [Level II evidence].

Insights & Cautions

Stratifies short-term risk of hemodynamic decompensation in normotensive PE but is modestly predictive and should not dictate therapy.

  • Underestimates risk when RV dysfunction or troponin elevation is present (ESC cohort data; OR ~2–3 for each predictor) 1.
  • Validated only in observational cohorts with variable definitions and limited external impact on management 2.
  • Use only as an adjunct to comprehensive PE risk assessment (clinical status, imaging, biomarkers).